ProKidney Newsroom

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Futu NewsNov 13 21:31

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Futu NewsNov 13 18:41

ProKidney Analyst Ratings

BenzingaSep 30 21:30

J.P. Morgan Initiates ProKidney(PROK.US) With Hold Rating

Futu NewsSep 30 17:31

ProKidney Initiated at Buy by Guggenheim

Dow JonesSep 10 17:58

Guggenheim Initiates Coverage On ProKidney With Buy Rating, Announces Price Target of $6

BenzingaSep 10 17:48

Guggenheim Initiates ProKidney(PROK.US) With Buy Rating, Announces Target Price $6

Futu NewsSep 10 17:31

Buy Rating on ProKidney: Promising Prospects in Chronic Kidney Disease Treatment

TipRanksSep 10 16:48

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Futu NewsSep 6 18:33

BofA Securities Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Futu NewsSep 4 21:32

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Futu NewsSep 4 21:32

ProKidney Is Maintained at Neutral by B of A Securities

Dow JonesSep 4 20:19

ProKidney Analyst Ratings

BenzingaSep 4 20:08

BofA Securities Maintains ProKidney(PROK.US) With Hold Rating, Cuts Target Price to $3

Futu NewsSep 4 18:31

Morgan Stanley Maintains ProKidney(PROK.US) With Hold Rating, Maintains Target Price $3

Futu NewsSep 4 18:31

Maintaining Hold on ProKidney Amid Strategic Shifts and Regulatory Uncertainties

TipRanksSep 4 18:09

ProKidney's Hold Rating Maintained Amid Financing and Clinical Uncertainties

TipRanksSep 4 17:50

BTIG Maintains ProKidney(PROK.US) With Buy Rating, Maintains Target Price $5

Futu NewsSep 4 16:31

ProKidney Analyst Ratings

BenzingaJun 11 02:20

Jefferies Maintains Buy on ProKidney, Lowers Price Target to $6

BenzingaJun 11 02:20